{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:44:46Z","timestamp":1774676686895,"version":"3.50.1"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260043-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Antipsychotics are increasingly used in the perinatal period. However, evidence of their effectiveness in the perinatal population is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260043-5\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the risk of severe psychiatric relapse during the perinatal period associated with discontinuation of antipsychotic treatment before or during pregnancy in women with primary psychotic disorders or bipolar disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260043-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study used linked Danish and Swedish national birth registers to identify pregnancies leading to singleton live births from 1998 to 2022 in Denmark and from 2007 to 2017 in Sweden. Women diagnosed with psychotic disorders or bipolar disorder, with a gestational age between 154 and 315 days, and 2 or more antipsychotic prescriptions filled within 1 year before pregnancy were included. Data were analyzed from August 2024 to October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260043-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>The exposure of interest was antipsychotic discontinuation. Discontinuation was defined as no prescription refill within the expected prescription duration plus a 60-day grace period. Women were classified into groups: prepregnancy discontinuation, pregnancy discontinuation, and continuation. The prepregnancy discontinuation group was matched 1:1 to the continuation group, and the pregnancy discontinuation group was separately matched 1:1 to the same continuation group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260043-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The outcome of interest was severe psychiatric relapse in the perinatal period. Hazard ratios (HRs) were estimated for psychiatric relapse, defined as inpatient treatment for psychiatric disorders during pregnancy and up to 3 months post partum, using a stratified Cox proportional hazards regression model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260043-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2000 women with primary psychotic disorders (1265 from Denmark and 735 from Sweden) and 1292 women with bipolar disorder (341 from Denmark and 951 from Sweden) were included. The mean (SD) age was 30.8 (6.0) years for women with psychotic disorders and 29.1 (7.7) years for women with bipolar disorder. For women with psychotic disorders discontinuing antipsychotics before pregnancy, the adjusted HR (AHR) of psychiatric relapse was 1.24 (95% CI, 0.82-1.90) compared with continuation. Pregnancy discontinuation had a higher point estimate for relapse risk (328 pairs; AHR, 1.60 [95% CI, 1.01-2.54]) compared with continuation of antipsychotics. Among women with bipolar disorder, prepregnancy discontinuation (102 pairs; AHR, 0.50 [95% CI, 0.22-1.11]) and pregnancy discontinuation (92 pairs; AHR, 1.00 [95% CI, 0.48-2.10]) point estimates did not show an increased risk of severe relapse, but statistical power was limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260043-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study, women with psychotic disorders who discontinued antipsychotic treatment during pregnancy were at a higher risk of severe relapse and the results for those who discontinued prepregnancy suggest a possible increase in risk, compared with those who continued, which aligns with findings observed beyond the perinatal period; results in women with bipolar disorder were inconclusive. There is an urgent need to investigate the effectiveness of antipsychotics on both severe and nonsevere relapses in the perinatal period in prospective clinical cohort studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.0682","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:30:25Z","timestamp":1774625425000},"page":"e260682","source":"Crossref","is-referenced-by-count":1,"title":["Risk of Relapse in Psychotic and Bipolar Disorders After Prenatal Antipsychotic Discontinuation"],"prefix":"10.1001","volume":"9","author":[{"given":"Xiaoqin","family":"Liu","sequence":"first","affiliation":[{"name":"The National Centre for Register-based Research, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelby","family":"Smout","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrang","family":"Mahjani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine","family":"Munk-Olsen","sequence":"additional","affiliation":[{"name":"The National Centre for Register-based Research, Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emely Ek","family":"Bl\u00e6hr","sequence":"additional","affiliation":[{"name":"The National Centre for Register-based Research, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thalia K.","family":"Robakis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Bergink","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Department of Psychiatry, Erasmus Medical Centre Rotterdam, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"4","key":"zoi260043r1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1017\/S2045796013000012","article-title":"Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey.","volume":"22","author":"Barbui","year":"2013","journal-title":"Epidemiol Psychiatr Sci"},{"key":"zoi260043r2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.schres.2020.03.048","article-title":"Antipsychotic drug use in pregnancy: a multinational study from ten countries.","volume":"220","author":"Reutfors","year":"2020","journal-title":"Schizophr Res"},{"issue":"2","key":"zoi260043r4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/wps.21089","article-title":"Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis.","volume":"22","author":"Leucht","year":"2023","journal-title":"World Psychiatry"},{"issue":"10202","key":"zoi260043r5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"zoi260043r6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.euroneuro.2021.08.264","article-title":"Preventing new episodes of bipolar disorder in adults: systematic review and meta-analysis of randomized controlled trials.","volume":"54","author":"Nestsiarovich","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"zoi260043r7","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1038\/s41380-020-00946-6","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.","volume":"26","author":"Kishi","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"14","key":"zoi260043r8","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: a review.","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"zoi260043r9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S2215-0366(24)00411-5","article-title":"Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort.","volume":"12","author":"Ermis","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"zoi260043r10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.schres.2014.07.034","article-title":"Discontinuation of antipsychotic medication in pregnancy: a cohort study.","volume":"159","author":"Petersen","year":"2014","journal-title":"Schizophr Res"},{"issue":"3","key":"zoi260043r11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1192\/bjp.2024.247","article-title":"Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study.","volume":"227","author":"Kang","year":"2025","journal-title":"Br J Psychiatry"},{"key":"zoi260043r12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.schres.2018.07.037","article-title":"Relapse in the first three months postpartum in women with history of serious mental illness.","volume":"204","author":"Taylor","year":"2019","journal-title":"Schizophr Res"},{"issue":"11","key":"zoi260043r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review.","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"issue":"2","key":"zoi260043r14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/dmd.112.050245","article-title":"Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?","volume":"41","author":"Isoherranen","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"21","key":"zoi260043r15","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1001\/jama.296.21.2582","article-title":"New parents and mental disorders: a population-based register study.","volume":"296","author":"Munk-Olsen","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"zoi260043r16","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.190","article-title":"Perinatal psychiatric episodes: a population-based study on treatment incidence and prevalence.","volume":"6","author":"Munk-Olsen","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"1","key":"zoi260043r17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","article-title":"The Danish Medical Birth Register.","volume":"33","author":"Bliddal","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"zoi260043r18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10654-022-00947-5","article-title":"The Swedish Medical Birth Register during five decades: documentation of the content and quality of the register.","volume":"38","author":"Cnattingius","year":"2023","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"zoi260043r19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models.","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi260043r20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1536867X0800800102","article-title":"metan: Fixed- and random-effects meta-analysis.","volume":"8","author":"Harris","year":"2008","journal-title":"Stata J"},{"issue":"2","key":"zoi260043r21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"2","key":"zoi260043r22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/aje\/kwt212","article-title":"Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching.","volume":"179","author":"Lunt","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"6","key":"zoi260043r23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"10","key":"zoi260043r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.38358","article-title":"Comparative effectiveness of antipsychotics in patients with schizophrenia spectrum disorder.","volume":"7","author":"Hamina","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260043r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003895","article-title":"Antidepressant discontinuation before or during pregnancy and risk of psychiatric emergency in Denmark: a population-based propensity score-matched cohort study.","volume":"19","author":"Liu","year":"2022","journal-title":"PLoS Med"},{"issue":"1","key":"zoi260043r27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40345-018-0135-7","article-title":"Lithium during pregnancy and after delivery: a review.","volume":"6","author":"Poels","year":"2018","journal-title":"Int J Bipolar Disord"},{"key":"zoi260043r28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jad.2021.08.006","article-title":"Bipolar episodes after reproductive events in women with bipolar I disorder, a study of 919 pregnancies.","volume":"295","author":"Gilden","year":"2021","journal-title":"J Affect Disord"},{"issue":"2","key":"zoi260043r29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.ajp.2015.15010124","article-title":"Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis.","volume":"173","author":"Wesseloo","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"8","key":"zoi260043r30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s40263-025-01202-7","article-title":"Management of bipolar disorder in pregnancy and postpartum: a clinicians\u2019 guide.","volume":"39","author":"Bergink","year":"2025","journal-title":"CNS Drugs"},{"issue":"11","key":"zoi260043r31","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1176\/appi.ps.201600408","article-title":"Antipsychotic medication use among publicly insured pregnant women in the United States.","volume":"68","author":"Park","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"4","key":"zoi260043r32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1399-5618.2006.00335.x","article-title":"Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder.","volume":"8","author":"Sharma","year":"2006","journal-title":"Bipolar Disord"},{"issue":"6","key":"zoi260043r33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1590\/1516-4446-2020-1629","article-title":"Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study.","volume":"43","author":"Uguz","year":"2021","journal-title":"Braz J Psychiatry"},{"issue":"Pt B","key":"zoi260043r34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120570","article-title":"Meta-analysis of recurrence rate and influencing factors of bipolar disorder.","volume":"394","author":"Bai","year":"2026","journal-title":"J Affect Disord"},{"key":"zoi260043r35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1403494810395825","article-title":"The Danish Psychiatric Central Research Register.","volume":"39","author":"Mors","year":"2011","journal-title":"Scand J Public Health"},{"issue":"6","key":"zoi260043r36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1600-0447.2011.01747.x","article-title":"Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden.","volume":"124","author":"Sellgren","year":"2011","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"zoi260043r37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00127-002-0582-3","article-title":"Young cases of schizophrenia identified in a national inpatient register\u2014are the diagnoses valid?","volume":"37","author":"Dalman","year":"2002","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"8","key":"zoi260043r38","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/s41380-024-02445-4","article-title":"Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.","volume":"29","author":"Vinkers","year":"2024","journal-title":"Mol Psychiatry"},{"key":"zoi260043r3","volume-title":"AHRQ Comparative Effectiveness Reviews No.43","author":"Maglione","year":"2011"},{"key":"zoi260043r24","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2847031\/liu_2026_oi_260043_1774025017.46228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:30:26Z","timestamp":1774625426000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.0682","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}